In the print version of the article listed above, the abbreviation of phenylalanine (Phe) as P is not correct. The “P333L” mutation should have read “F333L.” The online version reflects these changes.
. 2014 Jan 11;37(2):588. doi: 10.2337/dc14-er02b
Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
Katherine Q Philla
, Andrew J Bauer
, Karen S Vogt
, Siri Atma W Greeley
Katherine Q Philla
Find articles by Katherine Q Philla
Andrew J Bauer
Find articles by Andrew J Bauer
Karen S Vogt
Find articles by Karen S Vogt
Siri Atma W Greeley
Find articles by Siri Atma W Greeley
Issue date 2014 Feb.
© 2014 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
PMCID: PMC4392914
This corrects the article "Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation" in volume 36 on page e201.